News | November 23, 2008

Deborah Heart and Lung Center Begins Using Impella Device for High-Risk Cath Lab Patients

November 24, 2008 - Deborah Heart and Lung Center in Browns Mills, NJ said this week it successfully debuted the new Impella LP 2.5 minimally-invasive, catheter-based cardiac assist device in high-risk patients undergoing cardiac interventions.

The Impella 2.5, made by Abiomed, received FDA approval in June and is the world’s smallest heart pump. It is inserted through the skin in the cath lab via the femoral artery into the left ventricle of the heart. Up to 2.5 liters of blood per minute can then be continuously pumped from the left ventricle into the ascending aorta, providing the heart with active support in critical situations. With this steady blood flow, patients who were too critical to receive a cardiac intervention can now have life-saving treatment, Deborah officials said. Deborah is the first hospital in south Jersey to use this technology.

“Our first use of the Impella device for high risk PCI went very smoothly and successfully,” said Dr. Tommy Ng who heads up Deborah’s Impella team. “This offers a wide range of possibilities for patients who previously were not candidates for a cardiac intervention. This device has the potential to bring a fundamental shift for patients in the cath lab.”

“We are excited about this new technology,” said Dr. Manu Rajachandran, director of Deborah’s cardiac catheterization laboratory. “This will give us the ability to reach patients who were previously too medically fragile to undergo procedures which could save their lives. It is gratifying once again to be at the cutting-edge in medicine.”

Deborah Heart and Lung Center is a 139-bed teaching hospital that specializes in the diagnosis and treatment of congenital and acquired heart, lung and vascular diseases in adults, as well as providing outpatient cardiology services for children.

For more information: www.deborah.org

Related Content

Sponsored Content | Videos | Cardiovascular Ultrasound| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD)| June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Italian Boy Becomes Youngest Patient Bridged to Transplant With SynCardia Total Artificial Heart

Andrei, 12, is the world’s youngest patient to be bridged to transplant with the SynCardia Total Artificial Heart. He is pictured after his heart transplant with his surgeon, Antonio Amodeo, M.D., at Bambino Gesù Children’s Hospital in Rome, Italy. Photo courtesy of Business Wire.

News | Congenital Heart| June 22, 2017
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be...
Abiomed Impella CP pVAD, third-generation CP
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — Abiomed Inc.
tandemLife Tandemheart priming tray cleared by FDA
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to simp
Sponsored Content | Videos | Cardiovascular Ultrasound| May 26, 2017
This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Intraoperative Tr
Impella CP study to investigate door to left ventricular unloading time
News | May 09, 2017
May 9, 2017 — The first patient has been enrolled in the U.S.
Heartware HVAD recall for its ventricular assist device from Medtronic
Feature | Ventricular Assist Devices (VAD)| May 05, 2017
May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist De
the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock

Early use of the Impella percutaneous ventricular assist device prior to angioplasty may significantly improve survival for patients in cardiogenic shock.

Feature | Hemodynamic Support Devices| April 28, 2017 | Dave Fornell
Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment prot
Sponsored Content | Videos | Ventricular Assist Devices (VAD)| April 14, 2017
A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at
Overlay Init